Chimerix Inc (CMRX)

3.01 +0.16 (+5.61%) USD  |  NASDAQ  |  Dec 20, 16:00
2.99 -0.02 (-0.66%) After-Hours: 20:00
More

Chimerix Max Drawdown (5Y): 97.79% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for CMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Cumberland Pharmaceuticals Inc 84.73%
Abbott Laboratories 33.88%
Emergent BioSolutions Inc 98.89%
Tonix Pharmaceuticals Holding Corp 100.00%
Geovax Labs Inc 100.0%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -32.75
Beta (5Y) 1.018
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 84.00%
Historical Sharpe Ratio (5Y) -0.228
Historical Sortino (5Y) -0.4991
Monthly Value at Risk (VaR) 5% (5Y Lookback) 22.42%